These studies were designed to identify 1) a regimen of a third generation GnRH antagonist that abolishes primate luteal function, and 2) the amount of LH replacement required to maintain the structure and functional life span of the corpus luteum of the menstrual cycle after GnRH antagonist treatment. A single injection of antide at 3 or 5 mg/kg BW on day 6 of the luteal phase suppressed serum progesterone levels within 1 day of treatment, but levels recovered within 4 days. Administration of antide (3 mg/kg) for 3 days (luteal days 6 -8) reduced (P Ͻ 0.05) serum progesterone below 1 ng/mL and maintained these low levels for the entire sampling period; in subsequent experiments, all monkeys received this antide regimen. Fixed doses (5, 10, or 20 IU) of recombinant human LH administered at 8-h intervals during and after antide treatment stimulated progesterone production in a dose-dependent manner; these monkeys menstruated earlier than controls regardless of treatment group. Replacement with an escalating dose regimen (5-20 IU) of LH resulted in typical serum progesterone and relaxin levels throughout a luteal phase of normal length. Corpora lutea removed on day 10 from monkeys treated with antide alone had decreased wet weight (P Ͻ 0.05) and few large luteal cells; coadministration of the escalating dose regimen of LH maintained luteal structure similar to that seen in time-matched controls. Antide-only treatment increased progesterone receptor (PR) messenger ribonucleic acid, but decreased PR immunostaining in luteal tissue; the escalating dose regimen of LH maintained PR messenger ribonucleic acid and immunostaining similar to those in controls. This study indicates that during GnRH antagonist administration, an escalating dose regimen of LH replacement is optimal for maintenance of the structure and functional life span of the primate corpus luteum. (J Clin Endocrinol Metab 84: 342-349, 1999) L H IS ESSENTIAL for the proper development and function of the primate corpus luteum during the menstrual cycle. Administration of antibodies against LH to monkeys caused a premature decline of progesterone production (1), demonstrating the dependence of luteal function on continued LH exposure. After ablation of endogenous gonadotropin release by administration of a GnRH antagonist, replacement of gonadotropin activity with LH, but not FSH, restored luteal function (2). Administration of hCG, a LH-like gonadotropin, was also able to stimulate luteal progesterone production (3). However, the amount and pattern of LH exposure required to maintain the normal structure and functional life span of the corpus luteum of the menstrual cycle are unknown.Studies have examined the roles of LH pulse amplitude and frequency in the maintenance of the primate corpus luteum. In the macaque, frequent LH pulses of lower amplitude were measured in serum early in the luteal phase, but by days 10 -11 of the luteal phase, higher amplitude LH pulses were measured only three times daily (4). Monkeys with radiofrequency lesions to...